The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to ...

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, highlights increased data management, DE&I, and ...

Signature Program provides a personalized approach to treatment planning, in combination with Allergan Aesthetics' advanced facial portfolio to address patient needs and treat different areas of the ...

Four of our panelists discuss their favorite investments in the final installment of our 2025 stock-picking confab.

Several federal agencies have begun removing resources for underrepresented Americans from their webpages following President ...

President Trump’s executive order on January 23rd follows his repeal of Biden’s AI executive order, directing reviews of ...

The notice from SEC staff wasn’t legally binding, but companies tend to take such guidance as writ rather than suggestion.

New directive scraps Biden-era restrictions and accelerates AI innovation to bolster national security and economic growth.

Nvidia remained above the 50-day moving average Friday. Late Tuesday, President Donald Trump announced a joint venture called ...

Paul Howe, chief commercial officer at Protega, discusses efforts to combine high tech solutions with pain-management medications.

President Trump's rollback of Biden-era safety and security measures will speed up generative AI development, but without ...